X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (213) 213
index medicus (196) 196
vasculitis (134) 134
female (121) 121
male (112) 112
middle aged (89) 89
aged (84) 84
glomerulonephritis (73) 73
anti-neutrophil cytoplasmic antibody-associated vasculitis - immunology (72) 72
rheumatology (69) 69
adult (68) 68
wegeners-granulomatosis (68) 68
urology & nephrology (65) 65
anti-neutrophil cytoplasmic antibody-associated vasculitis - diagnosis (61) 61
anca-associated vasculitis (54) 54
anti-neutrophil cytoplasmic antibody-associated vasculitis - complications (53) 53
anti-neutrophil cytoplasmic antibody-associated vasculitis - drug therapy (53) 53
microscopic polyangiitis (51) 51
biopsy (50) 50
antibodies (48) 48
crescentic glomerulonephritis (43) 43
disease (43) 43
antibodies, antineutrophil cytoplasmic - blood (42) 42
retrospective studies (42) 42
treatment outcome (42) 42
antineutrophil cytoplasmic antibodies (41) 41
anti-neutrophil cytoplasmic antibody-associated vasculitis - pathology (40) 40
antibody-associated vasculitis (40) 40
immunosuppressive agents - therapeutic use (40) 40
medicine & public health (40) 40
autoantibodies (39) 39
systemic vasculitis (39) 39
nephrology (38) 38
neutrophils (38) 38
anca (35) 35
anti-neutrophil cytoplasmic antibody-associated vasculitis - blood (35) 35
anti-neutrophil cytoplasmic antibody-associated vasculitis - therapy (34) 34
viral antibodies (34) 34
glomerulonephritis - immunology (33) 33
kidney - pathology (33) 33
care and treatment (30) 30
immunology (30) 30
analysis (29) 29
adolescent (28) 28
aged, 80 and over (28) 28
small-vessel vasculitis (28) 28
animals (27) 27
cyclophosphamide (26) 26
peroxidase - immunology (26) 26
rituximab (26) 26
prognosis (25) 25
risk factors (25) 25
diagnosis (24) 24
patients (24) 24
antibodies, antineutrophil cytoplasmic - immunology (23) 23
health aspects (23) 23
pathogenesis (23) 23
anti-neutrophil cytoplasmic antibody (22) 22
anti-neutrophil cytoplasmic antibody-associated vasculitis - chemically induced (22) 22
autoimmunity (22) 22
granulomatosis (22) 22
time factors (22) 22
young adult (22) 22
disease progression (21) 21
glomerulonephritis - pathology (21) 21
kidney diseases (21) 21
glomerulonephritis - etiology (20) 20
immunoglobulins (20) 20
mortality (20) 20
renal vasculitis (20) 20
antineutrophil cytoplasmic autoantibodies (19) 19
child (19) 19
cyclophosphamide - therapeutic use (19) 19
inflammation (19) 19
rapidly progressive glomerulonephritis (19) 19
rodents (19) 19
article (18) 18
churg-strauss-syndrome (18) 18
classification (18) 18
granulomatosis with polyangiitis (18) 18
mice (18) 18
remission induction (18) 18
research (18) 18
therapy (18) 18
urine (18) 18
biomarkers - blood (17) 17
internal medicine (17) 17
kidneys (17) 17
proteins (17) 17
research article (17) 17
anti-neutrophil cytoplasmic antibody-associated vasculitis (16) 16
pathology (16) 16
recurrence (16) 16
abridged index medicus (15) 15
diagnosis, differential (15) 15
medicine (15) 15
randomized-trial (15) 15
severity of illness index (15) 15
urologic and male genital diseases (15) 15
anti-neutrophil cytoplasmic antibody-associated vasculitis - physiopathology (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Rheumatology, ISSN 0315-162X, 05/2013, Volume 40, Issue 5, pp. 674 - 683
Journal Article
Journal Article
Journal Article
Journal Article
Clinical and Experimental Immunology, ISSN 0009-9104, 11/2014, Volume 178, Issue 2, pp. 270 - 278
Journal Article
Current Opinion in Rheumatology, ISSN 1040-8711, 01/2018, Volume 30, Issue 1, pp. 30 - 35
PURPOSE OF REVIEWBiomarkers are considered to be helpful in diagnosing, monitoring, predicting treatment response, and prognosis in clinical practice and as... 
Behçet's syndrome | Kawasaki disease | large vessel vasculitis | biomarker | antineutrophil cytoplasmic antibody-associated vasculitis | Behcet's syndrome | MARKER | CLASSIFICATION | GRANULOMATOSIS | POLYANGIITIS WEGENERS | BEHCETS-DISEASE | RHEUMATOLOGY | DISEASE-ACTIVITY | TAKAYASUS-ARTERITIS | RELAPSE | RENAL VASCULITIS | Recurrence | Vasculitis - metabolism | Polyarteritis Nodosa - immunology | Prognosis | Mucocutaneous Lymph Node Syndrome - metabolism | Humans | Kidney Diseases - diagnosis | Leukocyte L1 Antigen Complex - metabolism | Temporal Arteries - diagnostic imaging | Mucocutaneous Lymph Node Syndrome - immunology | Receptors, Cell Surface | Positron-Emission Tomography | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - blood | Kidney Diseases - urine | Gastrointestinal Diseases - diagnosis | Antibodies, Antineutrophil Cytoplasmic - immunology | Vasculitis - immunology | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - diagnosis | Rituximab - therapeutic use | Ultrasonography | Behcet Syndrome - metabolism | Mucocutaneous Lymph Node Syndrome - diagnosis | Antirheumatic Agents - therapeutic use | Biomarkers - metabolism | Polyarteritis Nodosa - diagnosis | Autoantibodies | Myeloblastin - immunology | Antigens, CD - urine | Antigens, Differentiation, Myelomonocytic - urine | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Computed Tomography Angiography | Polyarteritis Nodosa - metabolism | Feces - chemistry | Gastrointestinal Diseases - metabolism | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - immunology | Vasculitis - diagnosis | Vasculitis | Research | Biological markers | Analysis
Journal Article
Indian Journal of Nephrology, ISSN 0971-4065, 03/2016, Volume 26, Issue 2, pp. 138 - 141
Journal Article
BMC Nephrology, ISSN 1471-2369, 06/2018, Volume 19, Issue 1, pp. 138 - 7
Background: Severe infections are common complications of immunosuppressive treatment for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis... 
Infection | Anti-neutrophil cytoplasmic antibody | Vasculitis | Lung | Risk factors | WEGENERS-GRANULOMATOSIS | SYSTEMIC VASCULITIS | ANTIBODY-ASSOCIATED VASCULITIS | CYCLOPHOSPHAMIDE | PNEUMONIA | RENAL VASCULITIS | RITUXIMAB | DISEASE | UROLOGY & NEPHROLOGY | INFLUENZA VACCINATION | JAPANESE PATIENTS | Pneumonia, Bacterial - blood | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Risk Factors | Male | Pneumonia, Bacterial - epidemiology | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - blood | Pneumonia, Bacterial - diagnosis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - diagnosis | Adult | Female | Immunosuppressive Agents - adverse effects | Aged | Retrospective Studies | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - epidemiology | Antibodies, Antineutrophil Cytoplasmic - blood | Cohort Studies | Care and treatment | Pneumonia | Bacterial pneumonia | Antibodies | Research | Viral antibodies | Cohort analysis | Chinese | Diagnosis | Health aspects | Corticoids | Mycophenolic acid | Intravenous administration | Laboratories | Lymphocytes T | Infections | Arthritis | Family medical history | Blood | Immunosuppressive agents | Fungi | Antineutrophil cytoplasmic antibodies | Glycosides | Urine | Creatinine | Cytomegalovirus | Statistical analysis | Kidneys | Multiple organ dysfunction syndrome | Neutrophils | Patients | CD4 antigen | Polymerase chain reaction | Cyclophosphamide | Influenza | Mycophenolate mofetil | Smoking
Journal Article
Human Pathology, ISSN 0046-8177, 06/2016, Volume 52, pp. 119 - 127
The histopathologic classification of antineutrophil cytoplasmic antibody–associated vasculitis has been demonstrated to have prognostic value in small cohorts... 
Glomerulonephritis | Vasculitis | Antineutrophil cytoplasmic antibody | Crescent | Kidney | WEGENERS-GRANULOMATOSIS | HISTOPATHOLOGICAL CLASSIFICATION | CRESCENTIC GLOMERULONEPHRITIS | ANCA-ASSOCIATED GLOMERULONEPHRITIS | VALIDATION | PATHOLOGY | SMALL-VESSEL VASCULITIS | HISTOLOGY | ANTIBODY-ASSOCIATED GLOMERULONEPHRITIS | CHINESE PATIENTS | EPIDEMIOLOGY | Predictive Value of Tests | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - pathology | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - mortality | Young Adult | Time Factors | Aged, 80 and over | Adult | Female | Retrospective Studies | Severity of Illness Index | Reproducibility of Results | Kidney Glomerulus - drug effects | Kaplan-Meier Estimate | Proportional Hazards Models | Glomerulonephritis - mortality | Treatment Outcome | Kidney Glomerulus - pathology | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Disease Progression | Glomerulonephritis - drug therapy | Spain | Biopsy | Glomerulonephritis - pathology | Aged | Cell Proliferation - drug effects | Viral antibodies | Antibodies | Analysis | Studies | Urine | Confidence intervals | Immunoglobulins | Hospitals | Microscopy | Rodents | Classification | Gangrene | Hospitalization | Kidney diseases
Journal Article